Mobile-health Network Solutions

MNDR Healthcare Health Information Services

Mobile-health Network Solutions' revenue for fiscal 2025 (year ended June 2025) was $7.6 million, down 45.3% from fiscal 2024.

0.92 0.17 −15.60%
Market cap
$1.3M
P/E
—
Fwd P/E
—
Dividend yield
—
F-score
2/9
Altman Z
−8.19
Beneish M
3.35
Dividend safety
n/a

Insider Decisions trades per month

Dec 25 Mar 26 Jun 26 Sep 26
Buy — — — — — — — — — — — —
Sell — — — — — — — — — — — —
Insider Ownership —

Capital & Financial Ratios $m

Market Cap 1.30
Revenue —
Net Income (18.99)
Free Cash Flow (12.44)
Net Debt (3.48)
Current Ratio 4.22 (at or above 1.5: strong)
Debt/Equity 0.00 (at or below 0.5: strong)
P/E ratio —
Fwd P/E —
P/S ratio —
P/B ratio 0.00
Past 5Y EPS Growth —
This Y EPS Growth 92.86% (at or above 15%: strong)
Next Y EPS Growth 150.00% (at or above 15%: strong)
Next Y revenue growth 496.99% (at or above 10%: strong)
Next 5Y EPS Growth —

Green and red mark values outside typical ranges. How we judge →

Valuation vs history

Dividends

Payout Ratio —
Annual Dividend Rate —
Annual Dividend Yield —

Assets vs Liabilities $m

2023 2024 2025 Q'25
Cash 2 7 1 3
Receivables 0 0 0 0
Inventory 0 0 0 0
Other 0 0 0 3
3 7 2 6
2023 2024 2025 Q'25
Payables 1 2 1 1
ST’ Debt — — — —
Other — — — —
3 3 2 2

Compound Annual Growth %

10y 5y 3y
Sales — — 3.04%
Cash Flow — — 0.00%
Earnings — — 0.00%
Book Value — — (32.31%)

Revenue $m

Mar Jun Sep Dec Year
’26 — — — — —
’25 — — — — 8
’24 — — — — 14
’23 — — — — 8
Fiscal quarters ending in the months shown.

Operating Cash Flow $m

Mar Jun Sep Dec Year
’26 — — — — —
’25 — — — — (4)
’24 — — — — (6)
’23 — — — — (2)
Fiscal quarters ending in the months shown.

Free Cash Flow $m

Mar Jun Sep Dec Year
’26 — — — — —
’25 — (4) — — (7)
’24 — (7) — — (7)
’23 — (2) — — (2)
Fiscal quarters ending in the months shown.

EPS $

Mar Jun Sep Dec Year
’26 — — — — —
’25 — — — — (22.92)
’24 — — — — (134.37)
’23 — — — — (7.12k)
Fiscal quarters ending in the months shown.

Target Price Range

Analyst price targets

Recommendation Rating

1
1Buy 2 3Hold 4 5Sell

Ten years at a glance Fiscal years to June

Group Line 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 Trend 2026e 2027e 2028e
Price, $
Price, $ Low — — — — — — — — 55.20 4.96

Analyst estimates 2026–2028

Powerpack
High — — — — — — — — 7,080.00 240.00
People
People Employees — — — — — — — 73 — 73
Revenue/emp, $m — — — — — — 0.00 0.11 0.00 0.10
Income, $m
Income, $m Revenue — — — — — — 7 8 14 8
Gross margin, % — — — — — — 27.69 13.90 18.17 16.74
EBT — — — — — — 0 (3) (16) (3)
EBT margin, % — — — — — — 3.70 (40.81) (111.84) (44.25)
Net income — — — — — — 0 (3) (16) (3)
Depreciation — — — — — — 0 0 0 0
Per share, $
Per share, $ Revenue — — — — — — 17,472.00 15,749.80 97.21 51.77
Earnings — — — — — — 257.43 (7,119.38) (134.37) (22.92)
Cash flow — — — — — — 2,439.25 (4,497.20) (44.57) (29.51)
Capex — — — — — — (38.00) (372.00) (0.93) (16.49)
Free cash flow — — — — — — 2,401.25 (4,869.20) (45.51) (46.01)
Book value — — — — — — 21,090.25 (734.40) 28.81 17.72
Shares, m — — — — — — 0 0 0 0
Valuation, ×
Valuation, × P/E — — — — — — — — — —
P/S — — — — — — — — — —
P/B — — — — — — 0.00 0.00 0.00 0.00
EV/Sales — — — — — — 0.00 0.00 0.00 0.00
EV/FCF — — — — — — 0.00 0.00 0.00 0.08
Cash, $m
Cash, $m Operating cash flow — — — — — — 1 (2) (6) (4)
Capex — — — — — — 0 0 0 (2)
Free cash flow — — — — — — 1 (2) (7) (7)
Balance, $m
Balance, $m Working capital — — — — — — 9 0 4 0
Total debt — — — — — — — — — —
Net debt — — — — — — (10) (2) (7) (1)
Shareholders’ equity — — — — — — 8 0 4 3
Returns, %
Returns, % ROA — — — — — — 0.00 (45.27) (273.90) (54.58)
ROIC — — — — — — 0.00 0.00 0.00 (139.99)
ROE — — — — — — 0.00 (79.65) (827.23) (100.17)
Negative figures in brackets.

All 10 years →

Fiscal years to Jun 2025

Charts ten years each

Mobile-health Network Solutions vs peers in Health Information Services (Q) = latest quarter vs a year earlier

Company Market cap P/E Fwd P/E Revenue growth (Q) EPS growth (Q) FCF growth (Q) Gross margin (Q) EBIT margin (Q) Compare
HLTHQ Cue Health Inc. $6.9M — (loss-making) — (loss-making) −87.19% (below 0%: shrinking) n/m +50.55% (above 0%: growing) (90.14%) (792.13%) Compare
ZCMD Zhongchao Inc. $6.2M — (loss-making) — +20.44% (above 0%: growing) −550.00% (below 0%: shrinking) +191.85% (above 0%: growing) 41.67% 0.00% Compare
ACON Aclarion, Inc. $5.6M — (loss-making) — (loss-making) +30.57% (above 0%: growing) n/m −41.41% (below 0%: shrinking) 32.94% (11,506.75%) Compare
VSEED VSee Health, Inc. $2.8M — (loss-making) — (loss-making) +48.02% (above 0%: growing) n/m −257.62% (below 0%: shrinking) 13.20% (172.69%) Compare
LGMK LogicMark, Inc. $1.7M — (loss-making) — (loss-making) +17.39% (above 0%: growing) n/m +96.41% (above 0%: growing) 70.71% (47.60%) Compare
MSPR MSP Recovery, Inc. $1.5M — (loss-making) — −94.60% (below 0%: shrinking) n/m +60.88% (above 0%: growing) (26.77%) (62,501.52%) Compare
MNDR Mobile-health Network Solutions $1.3M — — — — — — —
WORX SCWorx Corp. $1.1M 0.1× — (loss-making) +3.43% (above 0%: growing) n/m +87.99% (above 0%: growing) 46.80% (17.14%) Compare
ICCT iCoreConnect Inc. $800.0K — (loss-making) — −12.37% (below 0%: shrinking) n/m +91.63% (above 0%: growing) 74.39% (129.31%) Compare
Median of peers $2.3M — — +10.41% — +74.44% 37.31% (151.00%)

All 51 Health Information Services stocks →

Mobile-health Network Solutions (MNDR) key facts

  • Concern: Mobile-health Network Solutions' revenue for fiscal 2025 (year ended June 2025) was $7.6 million, down 45.3% from fiscal 2024.
  • Mobile-health Network Solutions (MNDR) is a Health Information Services company in the Healthcare sector, listed on Nasdaq.
  • As of October 16, 2026, MNDR traded at $0.92, a market capitalization of $1.3 million.
  • Return on equity was −100.2% and debt-to-equity 0.00.
  • Its Piotroski F-score is 2 out of 9 and its Altman Z-score is −8.19 (distress zone) for fiscal 2025.

Source: company filings (standardised) and stockrow calculations.

Mobile-health Network Solutions (MNDR) Latest News

stockrow.com/MNDR · Data as of Jun 30, 2025 · For information only; not investment advice. · © 2026 stockrow.com